HDL Remodeling During the Acute Phase Response

OBJECTIVE—The purpose of this study was to examine the interactive action of serum amyloid A (SAA), group IIA secretory phospholipase A2 (sPLA2-IIA), and cholesteryl ester transfer protein (CETP) on HDL remodeling and cholesterol efflux during the acute phase (AP) response elicited in humans after c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2009-02, Vol.29 (2), p.261-267
Hauptverfasser: Jahangiri, Anisa, de Beer, Maria C, Noffsinger, Victoria, Tannock, Lisa R, Ramaiah, Chandrashekar, Webb, Nancy R, van der Westhuyzen, Deneys R, de Beer, Frederick C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 267
container_issue 2
container_start_page 261
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 29
creator Jahangiri, Anisa
de Beer, Maria C
Noffsinger, Victoria
Tannock, Lisa R
Ramaiah, Chandrashekar
Webb, Nancy R
van der Westhuyzen, Deneys R
de Beer, Frederick C
description OBJECTIVE—The purpose of this study was to examine the interactive action of serum amyloid A (SAA), group IIA secretory phospholipase A2 (sPLA2-IIA), and cholesteryl ester transfer protein (CETP) on HDL remodeling and cholesterol efflux during the acute phase (AP) response elicited in humans after cardiac surgery. METHODS AND RESULTS—Plasma was collected from patients before (pre-AP), 24 hours after (AP-1 d), and 5 days after cardiac surgery (AP-5 d). SAA levels were increased 16-fold in AP-1 d samples. The activity of sPLA2-IIA was increased from 77.7±38.3 U/mL (pre-AP) to 281.4±57.1 U/mL (AP-1 d; P
doi_str_mv 10.1161/ATVBAHA.108.178681
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2760005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19008529</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5438-67f6a6bd00bba72dc21ebdd5d07242f1e3b499561ceba2e528635b5456e081943</originalsourceid><addsrcrecordid>eNpVkVFPwyAUhYnR6Jz-AR_MXnzsvFCg8GJSN3UmSzRGfSW0vbXVrl2g0_jvZdky9QEuN3znkHsg5IzCmFJJL9Pn1-t0lo4pqDFNlFR0jwyoYDziMpb74QyJjoTk7Igce_8OAJwxOCRHVAMowfSAjGfT-egJF12BTd2-jaYrty59haM0X_U4eqysx0D4Zdd6PCEHpW08nm7rkLzc3jxPZtH84e5-ks6jXPBYRTIppZVZAZBlNmFFzihmRSEKSBhnJcU441oLSXPMLEPBlIxFJriQCIpqHg_J1cZ3ucoWWOTY9s42ZunqhXXfprO1-X_T1pV56z4NS2QYUwQDtjHIXee9w3KnpWDW6ZlteqFXZpNeEJ3_ffVXso0rABdbwPrcNqWzbV77HceCl5Y6CRzfcF9d06PzH83qC52p0DZ9Zdb_EEsQEQPQEDaIwqIq_gH-WIcK</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>HDL Remodeling During the Acute Phase Response</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Jahangiri, Anisa ; de Beer, Maria C ; Noffsinger, Victoria ; Tannock, Lisa R ; Ramaiah, Chandrashekar ; Webb, Nancy R ; van der Westhuyzen, Deneys R ; de Beer, Frederick C</creator><creatorcontrib>Jahangiri, Anisa ; de Beer, Maria C ; Noffsinger, Victoria ; Tannock, Lisa R ; Ramaiah, Chandrashekar ; Webb, Nancy R ; van der Westhuyzen, Deneys R ; de Beer, Frederick C</creatorcontrib><description>OBJECTIVE—The purpose of this study was to examine the interactive action of serum amyloid A (SAA), group IIA secretory phospholipase A2 (sPLA2-IIA), and cholesteryl ester transfer protein (CETP) on HDL remodeling and cholesterol efflux during the acute phase (AP) response elicited in humans after cardiac surgery. METHODS AND RESULTS—Plasma was collected from patients before (pre-AP), 24 hours after (AP-1 d), and 5 days after cardiac surgery (AP-5 d). SAA levels were increased 16-fold in AP-1 d samples. The activity of sPLA2-IIA was increased from 77.7±38.3 U/mL (pre-AP) to 281.4±57.1 U/mL (AP-1 d; P&lt;0.001). CETP mass and activity reduction was commensurate to the reduction of HDL cholesterol levels. The combined action of SAA, sPLA2-IIA, and CETP in vitro markedly remodeled HDL with the generation of lipid-poor apoA-I from both pre-AP and AP-1 d HDL. The net result of this remodeling was a relative preservation of ABCA1- and ABCG1-dependent cholesterol efflux during the acute phase response. CONCLUSIONS—Our results show that the many and complex changes in plasma proteins during the acute phase response markedly remodel HDL with functional implications, particularly the relative retention of cholesterol efflux capacity.</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/ATVBAHA.108.178681</identifier><identifier>PMID: 19008529</identifier><identifier>CODEN: ATVBFA</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Acute-Phase Reaction - blood ; Acute-Phase Reaction - etiology ; Apolipoprotein A-I - blood ; Atherosclerosis (general aspects, experimental research) ; ATP Binding Cassette Transporter 1 ; ATP Binding Cassette Transporter, Sub-Family G, Member 1 ; ATP-Binding Cassette Transporters - blood ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiac Surgical Procedures - adverse effects ; Cardiology. Vascular system ; Cholesterol - blood ; Cholesterol Ester Transfer Proteins - blood ; Chromatography, Affinity ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; General and cellular metabolism. Vitamins ; Group II Phospholipases A2 - blood ; Humans ; Lipoproteins, HDL - blood ; Macrophages - metabolism ; Medical sciences ; Pharmacology. Drug treatments ; Recombinant Proteins - metabolism ; Serum Amyloid A Protein - metabolism ; Time Factors</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2009-02, Vol.29 (2), p.261-267</ispartof><rights>2009 American Heart Association, Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5438-67f6a6bd00bba72dc21ebdd5d07242f1e3b499561ceba2e528635b5456e081943</citedby><cites>FETCH-LOGICAL-c5438-67f6a6bd00bba72dc21ebdd5d07242f1e3b499561ceba2e528635b5456e081943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21089697$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19008529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jahangiri, Anisa</creatorcontrib><creatorcontrib>de Beer, Maria C</creatorcontrib><creatorcontrib>Noffsinger, Victoria</creatorcontrib><creatorcontrib>Tannock, Lisa R</creatorcontrib><creatorcontrib>Ramaiah, Chandrashekar</creatorcontrib><creatorcontrib>Webb, Nancy R</creatorcontrib><creatorcontrib>van der Westhuyzen, Deneys R</creatorcontrib><creatorcontrib>de Beer, Frederick C</creatorcontrib><title>HDL Remodeling During the Acute Phase Response</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVE—The purpose of this study was to examine the interactive action of serum amyloid A (SAA), group IIA secretory phospholipase A2 (sPLA2-IIA), and cholesteryl ester transfer protein (CETP) on HDL remodeling and cholesterol efflux during the acute phase (AP) response elicited in humans after cardiac surgery. METHODS AND RESULTS—Plasma was collected from patients before (pre-AP), 24 hours after (AP-1 d), and 5 days after cardiac surgery (AP-5 d). SAA levels were increased 16-fold in AP-1 d samples. The activity of sPLA2-IIA was increased from 77.7±38.3 U/mL (pre-AP) to 281.4±57.1 U/mL (AP-1 d; P&lt;0.001). CETP mass and activity reduction was commensurate to the reduction of HDL cholesterol levels. The combined action of SAA, sPLA2-IIA, and CETP in vitro markedly remodeled HDL with the generation of lipid-poor apoA-I from both pre-AP and AP-1 d HDL. The net result of this remodeling was a relative preservation of ABCA1- and ABCG1-dependent cholesterol efflux during the acute phase response. CONCLUSIONS—Our results show that the many and complex changes in plasma proteins during the acute phase response markedly remodel HDL with functional implications, particularly the relative retention of cholesterol efflux capacity.</description><subject>Acute-Phase Reaction - blood</subject><subject>Acute-Phase Reaction - etiology</subject><subject>Apolipoprotein A-I - blood</subject><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>ATP Binding Cassette Transporter 1</subject><subject>ATP Binding Cassette Transporter, Sub-Family G, Member 1</subject><subject>ATP-Binding Cassette Transporters - blood</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiac Surgical Procedures - adverse effects</subject><subject>Cardiology. Vascular system</subject><subject>Cholesterol - blood</subject><subject>Cholesterol Ester Transfer Proteins - blood</subject><subject>Chromatography, Affinity</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>General and cellular metabolism. Vitamins</subject><subject>Group II Phospholipases A2 - blood</subject><subject>Humans</subject><subject>Lipoproteins, HDL - blood</subject><subject>Macrophages - metabolism</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Recombinant Proteins - metabolism</subject><subject>Serum Amyloid A Protein - metabolism</subject><subject>Time Factors</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkVFPwyAUhYnR6Jz-AR_MXnzsvFCg8GJSN3UmSzRGfSW0vbXVrl2g0_jvZdky9QEuN3znkHsg5IzCmFJJL9Pn1-t0lo4pqDFNlFR0jwyoYDziMpb74QyJjoTk7Igce_8OAJwxOCRHVAMowfSAjGfT-egJF12BTd2-jaYrty59haM0X_U4eqysx0D4Zdd6PCEHpW08nm7rkLzc3jxPZtH84e5-ks6jXPBYRTIppZVZAZBlNmFFzihmRSEKSBhnJcU441oLSXPMLEPBlIxFJriQCIpqHg_J1cZ3ucoWWOTY9s42ZunqhXXfprO1-X_T1pV56z4NS2QYUwQDtjHIXee9w3KnpWDW6ZlteqFXZpNeEJ3_ffVXso0rABdbwPrcNqWzbV77HceCl5Y6CRzfcF9d06PzH83qC52p0DZ9Zdb_EEsQEQPQEDaIwqIq_gH-WIcK</recordid><startdate>200902</startdate><enddate>200902</enddate><creator>Jahangiri, Anisa</creator><creator>de Beer, Maria C</creator><creator>Noffsinger, Victoria</creator><creator>Tannock, Lisa R</creator><creator>Ramaiah, Chandrashekar</creator><creator>Webb, Nancy R</creator><creator>van der Westhuyzen, Deneys R</creator><creator>de Beer, Frederick C</creator><general>American Heart Association, Inc</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>200902</creationdate><title>HDL Remodeling During the Acute Phase Response</title><author>Jahangiri, Anisa ; de Beer, Maria C ; Noffsinger, Victoria ; Tannock, Lisa R ; Ramaiah, Chandrashekar ; Webb, Nancy R ; van der Westhuyzen, Deneys R ; de Beer, Frederick C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5438-67f6a6bd00bba72dc21ebdd5d07242f1e3b499561ceba2e528635b5456e081943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Acute-Phase Reaction - blood</topic><topic>Acute-Phase Reaction - etiology</topic><topic>Apolipoprotein A-I - blood</topic><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>ATP Binding Cassette Transporter 1</topic><topic>ATP Binding Cassette Transporter, Sub-Family G, Member 1</topic><topic>ATP-Binding Cassette Transporters - blood</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiac Surgical Procedures - adverse effects</topic><topic>Cardiology. Vascular system</topic><topic>Cholesterol - blood</topic><topic>Cholesterol Ester Transfer Proteins - blood</topic><topic>Chromatography, Affinity</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>General and cellular metabolism. Vitamins</topic><topic>Group II Phospholipases A2 - blood</topic><topic>Humans</topic><topic>Lipoproteins, HDL - blood</topic><topic>Macrophages - metabolism</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Recombinant Proteins - metabolism</topic><topic>Serum Amyloid A Protein - metabolism</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jahangiri, Anisa</creatorcontrib><creatorcontrib>de Beer, Maria C</creatorcontrib><creatorcontrib>Noffsinger, Victoria</creatorcontrib><creatorcontrib>Tannock, Lisa R</creatorcontrib><creatorcontrib>Ramaiah, Chandrashekar</creatorcontrib><creatorcontrib>Webb, Nancy R</creatorcontrib><creatorcontrib>van der Westhuyzen, Deneys R</creatorcontrib><creatorcontrib>de Beer, Frederick C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jahangiri, Anisa</au><au>de Beer, Maria C</au><au>Noffsinger, Victoria</au><au>Tannock, Lisa R</au><au>Ramaiah, Chandrashekar</au><au>Webb, Nancy R</au><au>van der Westhuyzen, Deneys R</au><au>de Beer, Frederick C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HDL Remodeling During the Acute Phase Response</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2009-02</date><risdate>2009</risdate><volume>29</volume><issue>2</issue><spage>261</spage><epage>267</epage><pages>261-267</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><coden>ATVBFA</coden><abstract>OBJECTIVE—The purpose of this study was to examine the interactive action of serum amyloid A (SAA), group IIA secretory phospholipase A2 (sPLA2-IIA), and cholesteryl ester transfer protein (CETP) on HDL remodeling and cholesterol efflux during the acute phase (AP) response elicited in humans after cardiac surgery. METHODS AND RESULTS—Plasma was collected from patients before (pre-AP), 24 hours after (AP-1 d), and 5 days after cardiac surgery (AP-5 d). SAA levels were increased 16-fold in AP-1 d samples. The activity of sPLA2-IIA was increased from 77.7±38.3 U/mL (pre-AP) to 281.4±57.1 U/mL (AP-1 d; P&lt;0.001). CETP mass and activity reduction was commensurate to the reduction of HDL cholesterol levels. The combined action of SAA, sPLA2-IIA, and CETP in vitro markedly remodeled HDL with the generation of lipid-poor apoA-I from both pre-AP and AP-1 d HDL. The net result of this remodeling was a relative preservation of ABCA1- and ABCG1-dependent cholesterol efflux during the acute phase response. CONCLUSIONS—Our results show that the many and complex changes in plasma proteins during the acute phase response markedly remodel HDL with functional implications, particularly the relative retention of cholesterol efflux capacity.</abstract><cop>Philadelphia, PA</cop><pub>American Heart Association, Inc</pub><pmid>19008529</pmid><doi>10.1161/ATVBAHA.108.178681</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 2009-02, Vol.29 (2), p.261-267
issn 1079-5642
1524-4636
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2760005
source MEDLINE; Alma/SFX Local Collection; Journals@Ovid Complete
subjects Acute-Phase Reaction - blood
Acute-Phase Reaction - etiology
Apolipoprotein A-I - blood
Atherosclerosis (general aspects, experimental research)
ATP Binding Cassette Transporter 1
ATP Binding Cassette Transporter, Sub-Family G, Member 1
ATP-Binding Cassette Transporters - blood
Biological and medical sciences
Blood and lymphatic vessels
Cardiac Surgical Procedures - adverse effects
Cardiology. Vascular system
Cholesterol - blood
Cholesterol Ester Transfer Proteins - blood
Chromatography, Affinity
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
General and cellular metabolism. Vitamins
Group II Phospholipases A2 - blood
Humans
Lipoproteins, HDL - blood
Macrophages - metabolism
Medical sciences
Pharmacology. Drug treatments
Recombinant Proteins - metabolism
Serum Amyloid A Protein - metabolism
Time Factors
title HDL Remodeling During the Acute Phase Response
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T06%3A54%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HDL%20Remodeling%20During%20the%20Acute%20Phase%20Response&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Jahangiri,%20Anisa&rft.date=2009-02&rft.volume=29&rft.issue=2&rft.spage=261&rft.epage=267&rft.pages=261-267&rft.issn=1079-5642&rft.eissn=1524-4636&rft.coden=ATVBFA&rft_id=info:doi/10.1161/ATVBAHA.108.178681&rft_dat=%3Cpubmed_cross%3E19008529%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19008529&rfr_iscdi=true